Semba Charles Pauling
SEC CIK 1872863 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Dir | 48.0K | $50.0K | — | 5 | 2023-01-03 | 2026-01-02 |
Most active insiders at DMAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRILL AB | 10% | $7.63M | — |
| 2 | Semba Charles Pauling | Dir | — | — |
| 3 | Pauls Dietrich John | Pres, CEO, Dir | — | — |
| 4 | Parsons James T. | Dir | — | — |
| 5 | Giuffre Randall Michael | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-02 | DMAC | DiaMedica Therapeutics Inc. | Semba Charles Pauling | Dir | A - Grant | $8.42 | +3,355 | 48.0K | +8% | +$28.2K | |
| 2025-01-03 | 2025-01-02 | DMAC | DiaMedica Therapeutics Inc. | Semba Charles Pauling | Dir | A - Grant | $5.34 | +5,290 | 44.6K | +13% | +$28.2K | |
| 2024-01-02 | 2024-01-02 | DMAC | DiaMedica Therapeutics Inc. | Semba Charles Pauling | Dir | A - Grant | $2.80 | +9,375 | 39.3K | +31% | +$26.2K | |
| 2023-06-26 | 2023-06-23 | DMAC | DiaMedica Therapeutics Inc. | Semba Charles Pauling | Dir | P - Purchase | $3.91 | +12.8K | 29.9K | +75% | +$50.0K | |
| 2023-01-03 | 2023-01-03 | DMAC | DiaMedica Therapeutics Inc. | Semba Charles Pauling | Dir | A - Grant | $1.53 | +17.2K | 17.2K | New | +$26.2K |
Purchase Sale Sale after option exercise All abbreviations